Table 1.
General demographic clinical and laboratory characteristics of 740 participants.
| Variable | Frequency | Median (IQR) or percentage |
|---|---|---|
| Age in years | 740 | 35 [27–42] |
| Age group | ||
| ≥45 years | 156 | 21.1 |
| <45 years | 584 | 78.9 |
| Sex | ||
| Male | 275 | 37.2 |
| Female | 465 | 62.8 |
| Marital status | ||
| Married | 278 | 37.6 |
| Divorced | 160 | 21.6 |
| Widow | 154 | 20.8 |
| Single | 51 | 6.9 |
| WHO stage | ||
| 3 & 4 | 261 | 35.3 |
| 1 & 2 | 479 | 64.7 |
| Baseline CD4 (cell/µl) | 740 | 256 [132–469] |
| Baseline CD4 group | ||
| ≤200 cell/µl | 258 | 34.9 |
| >200 cell/µl | 482 | 65.1 |
| Hemoglobin (g/dL) | 740 | 11.4 [9.7–13.1] |
| Normal HB | 452 | 61.1 |
| Anemia total | 288 | 38.9 |
| Mild anemia | 147 | 19.9 |
| Moderate anemia | 88 | 11.9 |
| Severe anemia | 53 | 7.2 |
| OI on diagnosis | ||
| Tuberculosis | 197 | 26.6 |
| Others | 543 | 73.4 |
| Outcome on ART | ||
| Median time (Mo) | 740 | 27 [17–37] |
| Dead | 86 | 11.6 |
| Alive | 654 | 88.4 |
ART: antiretroviral therapy; CD4: cluster of differentiation 4; dl: deciliter; HB: hemoglobin; IQR: interquartile range; Mo: months; OI: opportunistic infection; WHO: World Health Organization.